SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899866-19-000104
Filing Date
2019-12-04
Accepted
2019-12-04 18:38:31
Documents
1
Period of Report
2019-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 3/A wf-form3a_157550269426031.html 3/A  
1 FORM 3/A wf-form3a_157550269426031.xml 3/A 2840
  Complete submission text file 0000899866-19-000104.txt   4313
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Issuer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ALEXION PHARMACEUTICALS, INC. 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address
Bazarko Daniel (Reporting) CIK: 0001768214 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-27756 | Film No.: 191269128